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Background: Older adults are at risk for severe pulmonary embolism (PE) and may require advanced therapies besides anticoagulation. 
However, trends in the use of advanced therapies are unknown.
methods: We analyzed the use of inferior vena caval filter (IVCF) placement, thrombolytic therapy, surgical, and percutaneous 
thrombectomy among Fee-For-Service Medicare beneficiaries >65 years with PE from 1999 to 2010. We calculated use per 1000 PE 
patients, along with 30-day and 1-year mortality rates after the use of these therapies.
results: Among 556,658 patients hospitalized with PE, 94,427 underwent IVCF placement, 7158 received thrombolytic therapy, 676 
underwent surgical thrombectomy, and 260 had percutaneous thrombectomy. The number and rate of IVCF placement increased from 
1999 to 2010 (P<0.001 and P=0.11 for trend, respectively), while 30-day, and 1-year mortality rates declined among IVCF recipients 
(P<0.01 for both). Thrombolytic therapy, surgical, and percutaneous thrombectomy were rare, with slight increases in rates of thrombolytic 
therapy and percutaneous thrombectomy over time (P=0.09 and P<0.001 for trend, Table) but no significant change in mortality rates.
conclusion:  The use of advanced PE therapies in older adults has been dominated by IVCF placement, with an associated decreased 
mortality for those who received it, whereas thrombolytic therapy and thrombectomy have been rarely performed.
